First African Approvals For Merck’s Ebola Vaccine
A Collaborative Effort Has Secured Rapid Licensing
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.
You may also be interested in...
Following its recent EU approval, moves are under way to make Merck’s Ervebo vaccine available in countries at risk of Ebola.
As discussions continue over the European Commission’s plans to overhaul the EU pharmaceutical legislation, the R&D-based pharma industry body EFPIA says that any new pharma policy framework will need to be stable, fast, effective and globally competitive.
Proposals on medicines put forward by the European Commission are part of a package of measures to improve the implementation of the Northern Ireland Protocol by relaxing checks on goods moving across the Irish sea.